Related Experiment Videos
Radiation-recall dermatitis in a patient treated with paclitaxel
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Personality traits and disorders in people with body dysmorphic disorder (BDD): A systematic review.
Journal of psychiatric research·2026
Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Consumer and clinician perspectives on personalising breast cancer prevention information.
Breast (Edinburgh, Scotland)·2018
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.
European journal of cancer (Oxford, England : 1990)·2017
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026